Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients.
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor.
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.
Krabbe disease: One Hundred years from the bedside to the bench to the bedside.
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
Thrombin and Protein C Pathway in Peripheral Nerve Schwann Cells.
Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Efficacy and tolerability of dimethyl fumarate in White-, African- and Hispanic- Americans with multiple sclerosis.
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Progressive Multiple Sclerosis.
Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
Validation of the Oxford Participation and Activities Questionnaire.
Relationships between trunk performance, gait and postural control in persons with multiple sclerosis.
Corrigendum to "Evolution of diagnostic criteria for multiple sclerosis" [Pol. J. Neurol. Neurosurg. 49 (5) (2015) 313-321].
Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.
Deep brain stimulation for the treatment of uncommon tremor syndromes.
The axon as a physical structure in health and acute trauma.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
Distribution-based estimates of minimum clinically important difference in cognition, arm function and lower body function after slow release-fampridine treatment of patients with multiple sclerosis.
Type 1 diabetes and susceptibility to multiple sclerosis: What is the truth?
Examining the Relationship Between Family Caregivers' Emotional States and Ability to Empathize with Patients with Multiple Sclerosis: A Pilot Study.
Pages
« first
‹ previous
…
842
843
844
845
846
847
848
849
850
…
next ›
last »